Race to Become Clinician OS

The winning product is shifting from a reference tool into the operating system around the doctor visit. Once a product already sits in the clinician workflow, it can move sideways from answering a research question into writing the note, suggesting billing codes, placing follow up calls, and eventually pulling patient context from the EHR, which raises switching costs and turns a single use app into a daily habit.

• Abridge starts with the conversation itself. It records the visit, turns speech into a structured note inside Epic, and can surface more complete codes and modifiers. That makes research a natural add on, because the same app already knows what patient problem the doctor is dealing with.
  3 sacra 4 sacra
• Doximity starts with distribution, not documentation. Its network, calling, and lightweight workflow tools work bottom up because they can avoid patient data. That makes it strong at owning clinician attention, but deeper note writing and order entry still push the product toward heavier enterprise integration.
  2 sacra 5 sacra
• OpenEvidence is trying to collapse the old tool stack. Doctors historically bounced between UpToDate for research, Lexicomp for drug data, Abridge for notes, and separate prior auth tools. Embedding literature search inside EHR connected workflows lets one surface absorb several paid seats and several daily clicks.
  1 sacra 4 sacra

The next phase is a battle over who becomes the default pane of glass inside clinical workflow. UpToDate brings trust and enterprise contracts. Abridge brings transcript level context. Doximity brings physician reach. OpenEvidence and ChatGPT for Clinicians bring free adoption at scale. The product that best connects research, documentation, and action inside the EHR will compound fastest.